Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex

Bert Bosche, Rudolf Graf, Ralf-Ingo Ernestus, Christian Dohmen, Thomas Reithmeier, Gerrit Brinker, Anthony J Strong, Jens P Dreier, Johannes Woitzik, Members of the Cooperative Study of Brain Injury Depolarizations (COSBID), Bert Bosche, Rudolf Graf, Ralf-Ingo Ernestus, Christian Dohmen, Thomas Reithmeier, Gerrit Brinker, Anthony J Strong, Jens P Dreier, Johannes Woitzik, Members of the Cooperative Study of Brain Injury Depolarizations (COSBID)

Abstract

Objective: Delayed ischemic neurological deficit (DIND) contributes to poor outcome in subarachnoid hemorrhage (SAH) patients. Because there is continuing uncertainty as to whether proximal cerebral artery vasospasm is the only cause of DIND, other processes should be considered. A potential candidate is cortical spreading depolarization (CSD)-induced hypoxia. We hypothesized that recurrent CSDs influence cortical oxygen availability.

Methods: Centers in the Cooperative Study of Brain Injury Depolarizations (COSBID) recruited 9 patients with severe SAH, who underwent open neurosurgery. We used simultaneous, colocalized recordings of electrocorticography and tissue oxygen pressure (p(ti)O(2)) in human cerebral cortex. We screened for delayed cortical infarcts by using sequential brain imaging and investigated cerebral vasospasm by angiography or time-of-flight magnetic resonance imaging.

Results: In a total recording time of 850 hours, 120 CSDs were found in 8 of 9 patients. Fifty-five CSDs ( approximately 46%) were found in only 2 of 9 patients, who later developed DIND. Eighty-nine ( approximately 75%) of all CSDs occurred between the 5th and 7th day after SAH, and 96 (80%) arose within temporal clusters of recurrent CSD. Clusters of CSD occurred simultaneously, with mainly biphasic CSD-associated p(ti)O(2) responses comprising a primary hypoxic and a secondary hyperoxic phase. The frequency of CSD correlated positively with the duration of the hypoxic phase and negatively with that of the hyperoxic phase. Hypoxic phases significantly increased stepwise within CSD clusters; particularly in DIND patients, biphasic p(ti)O(2) responses changed to monophasic p(ti)O(2) decreases within these clusters. Monophasic hypoxic p(ti)O(2) responses to CSD were found predominantly in DIND patients.

Interpretation: We attribute these clinical p(ti)O(2) findings mainly to changes in local blood flow in the cortical microcirculation but also to augmented metabolism. Besides classical contributors like proximal cerebral vasospasm, CSD clusters may reduce O(2) supply and increase O(2) consumption, and thereby promote DIND.

Figures

FIGURE 1
FIGURE 1
X-ray topographic images and cranial computed tomography (CT) slices of Patients 1 and 2 with individual locations of the electrocorticography (ECoG) strip electrodes (arrows, CT artifacts of electrodes) and the oxygen partial pressure probes (arrowheads) adjacent to strip electrodes. Please note that levels of axial sections differ somewhat among scans. The upper level shows Patient 1, with subarachnoid hemorrhage predominantly in the sylvian fissure with additional intraparenchymal hemorrhage and perifocal space-occupying edema. (A-D) A CT scan was performed after decompressive craniectomy with ECoG and tissue oxygen pressure (ptiO2) probe implantation 2 days after subarachnoid hemorrhage (SAH). (A) In the topogram, the arrows represent 6 single electrodes of the ECoG strip electrode. The arrowhead demarcates the ptiO2 probe. (B) The arrow indicates electrode 2. (C) Arrows indicate electrodes 3 and 4, respectively. (D) The arrow indicates electrode 5, and the arrowhead demarcates the ptiO2 probe. (E) Perfusion-weighted (PW) magnetic resonance imaging (MRI) and (F) diffusion-weighted (DW) MRI show no perfusion deficit or signs of cortical ischemia 4 days after SAH. The area of intracranial hemorrhage displays disturbance of the diffusion signal. (G) PW MRI and (H) DW MRI demonstrate areas of hypoperfusion and signs of cortical ischemia predominantly of the right frontal lobe, but also of the left frontal lobe 9 days after SAH. (I) MRI (T1 weighted) shows infarcted cortical tissue. (J) A T2-weighted MRI cross-section (more rostral) gives a detailed picture of the distribution of cortical infarcts with right frontoparietal and bifrontal representation. The lower level shows Patient 2, who suffered a subarachnoid hemorrhage from a ruptured aneurysm, which was clipped surgically 2 days after SAH. Cranial CT scan was performed 1 day after the craniotomy and ECoG and ptiO2 probe implantation. (K) X-ray topogram and (K-M) 2 different slices are depicted. (K) Six arrows indicate the ECoG strip with 6 single electrodes. The arrowhead demarcates the ptiO2 probe. (L) The arrows indicate electrodes 1, 2, and 3; the arrowhead indicates the ptiO2 probe between electrodes 2 and 3. (M) All 6 electrodes are displayed; however, the ptiO2 probe is not visible on this cross section. (N) Seven days after SAH, PW MRI showed no hypoperfusion, and (O) DW MR imaging revealed no signs of ischemia (disturbance of diffusion). (P) The same was true for the T1-weighted MRI and also (Q) for T2-weighted MRI (see Supplementary Clinical Results online for a more detailed description of the 2 individual clinical courses).
FIGURE 2
FIGURE 2
Subdural electrocorticography (ECoG). (A) A representative electrocorticogram 5 days after subarachnoid hemorrhage (SAH) over a time period of 40 minutes (Patient 2). The upper 4 traces (channels A, B, C, and D) demonstrate the high-passed filtered ECoG data. The ECoG displays a cortical spreading depression (CSD, arrows) propagating from channel B through C to D. The middle 4 traces show the integrals of each ECoG channel, with the corresponding integral changes indicated with arrows. The lowermost 4 show the power of ECoG and the rapid reduction of power due to the CSD. Time period from arrows to hash symbols represents the duration of the CSD4; channel D shows the longest duration of this typical CSD. Scales shown in channel D are also representative for the channels A, B, and C, respectively. (B) Schema of ECoG electrode strip: 5 bipolar electrodes generate the 4 channels: A, B, C, and D. The 6th electrode can be used as ground. (C) Histogram of CSD occurrence in SAH patients (n = 8; for day 1, n = 6) demonstrates that most CSDs (89 of 120 CSDs, ∼75%) occur between the 5th and 7th day after SAH.
FIGURE 3
FIGURE 3
Coregistration of electrocorticography (ECoG) and tissue oxygen pressure (ptiO2). (A) A cluster of repetitive cortical spreading depolarizations (CSDs) in association with transient biphasic ptiO2 responses demonstrated in the coregistration of ECoG (lower line) and ptiO2 measurement (upper line) of a subarachnoid hemorrhage patient over a time period of 10 hours (Patient 5). Channel D (integral [int.]) is shown. The 3 CSDs are marked by the arrows; arrowheads demonstrate the corresponding biphasic ptiO2 responses. The long time period and the low baseline level of the ECoG integral reveal the spatial and temporal association with ptiO2 responses. (B) The enlargement of temporal resolution of a certain time period (rectangle in part A) and the addition of a second ECoG channel (C) (raw data and integral) reveal the exact CSD propagation (arrows) from channel D to C and the clear temporal relationship with the corresponding biphasic ptiO2 response (arrowhead).
FIGURE 4
FIGURE 4
Three different types of tissue oxygen pressure (ptiO2) responses are found in the cortex of subarachnoid hemorrhage (SAH) patients in spatial and temporal association with cortical spreading depolarizations (CSDs). (A) Biphasic ptiO2 response with an initial decrease and a secondary increase, monophasic ptiO2 decrease, and monophasic ptiO2 increase. Arrows indicate the start of CSD in the electrocorticography (ECoG) channel next to the ptiO2 probe. (B) Magnification of the biphasic ptiO2 response of part A. Further detailed ptiO2 response analyses reveal values of specific features, integrals, and subareas of the ptiO2-curve: BASE = ptiO2 at baseline (30.60 [25.25, 36.70] mmHg), MINhypo= the minimum (23.90 [16.75, 32.38] mmHg), DURhypo= the duration (345 [207.5, 502.5] seconds), and INThypo= the integral (12.76 [3.87, 18.94] arbitrary units [aU]) of the initial hypoxic phase. descINThypo= (grey-shaded) integral representing the phase we designate “descent area,” that is, the area under the curve from start to minimum of the hypoxic phase. MAXhyper= the maximum (38.00 [28.30, 45.00] mmHg), DURhyper= the duration (720.0 [540.0, 1090.0] seconds), and INThyper= the integral (40.00 [12.50, 124.28] aU) of the secondary hyperoxic phase; ascINThyper= second (grey-shaded) integral depicting an ascent area, that is, the area from start to maximum of the secondary hyperoxic phase. In some cases (compare with Fig 4A), ptiO2 shows an asymptotic return to ptiO2 baseline, which may distort curve analysis; thus the grey-shaded areas are additionally scrutinized to avoid this distortion. (C) Relative percentage frequencies of different ptiO2 responses to ECoG events (90 CSDs). Clear spatial and temporal associations of ptiO2 responses with EcoG events are found in 53.3 (42.7, 67.1)% of the CSDs (in total 47 of 90 CSDs, with association rates up to 90% in single individuals). The differentiation of all CSD-associated ptiO2 response types demonstrates that the biggest portion is contributed by biphasic ptiO2 responses (Bi); monophasic increases (MI) were rare in the severe SAH patients, and monophasic decreases (MD) were more frequent. (D) The 3 different ptiO2responses (compare with part C) in total ∼100% and their distribution of SAH patients with no ischemic neurological deficit (DIND) (white bars) versus SAH patients with DIND (black bars). All monophasic ptiO2 increases were found in SAH patients with no DIND and good outcome (extended Glasgow Outcome Scale ≥ 6). Biphasic ptiO2 responses were approximately similar in both patient groups, whereas monophasic decreases were typically found in patients developing DIND.
FIGURE 5
FIGURE 5
Cortical spreading depolarization (CSDs) within clusters and corresponding tissue oxygen pressure (ptiO2) responses. (A) An example (taken from Patient 1, 6 days after subarachnoid hemorrhage [SAH]) of 4 repetitive CSD-associated ptiO2 responses within a cluster (arrows in A–C represent start of CSD). The 1st ptiO2 response was biphasic, the 2nd and 3rd showed stepwise augmentation of primary hypoxic phases of the ptiO2 responses with subsequent small or almost nonexisting secondary hyperoxic phases, and the 4th showed a drastically enlarged hypoxic phase. Please note that particularly in the 4th ptiO2 response, the baseline level was not restored. This example shows an immediate transition from a biphasic to a monophasic decrease pattern of the ptiO2 response and may therefore reveal a change from normal to inverse neurovascular coupling and/or increased oxygen consumption, with the likelihood of secondary cortical ischemia after SAH. (B) The second example (taken from Patient 2, 7 days after SAH) of 4 repetitive CSD-associated ptiO2 responses within a cluster (arrows, see above). The primary hypoxic phases were stepwise slightly enlarged beginning with the 1st, then the 2nd, 3rd, and 4th response; however, a similar extension was seen in the secondary hyperoxic phases. In this example, all ptiO2 responses were biphasic in nature, and the ptiO2 baseline level was subsequently reestablished or even slightly exceeded, possibly representing normal (compensatory hyperemic) neurovascular coupling and/or simply transiently increased oxygen consumption not leading to ischemic transformation after SAH. (C) Examples of 2 CSD-associated ptiO2 responses with a rapid sequence of CSDs. Note that the period from 1st to 2nd CSD lasts only ∼12 minutes. The first ptiO2 response showed a biphasic pattern with a small hypoxic and a relatively large secondary hyperoxic phase, whereas the 2nd response revealed a deeper and prolonged hypoxic phase without a secondary hyperoxic phase, that is, a monophasic decrease of ptiO2. This example demonstrates a rapid transition from biphasic to monophasic decreasing ptiO2 pattern, perhaps due to the very small period between 2 repetitive CSDs. (D, E) Analysis of CSDs and corresponding ptiO2 responses within clusters. Box plots represent CSDs categorized by their specific order (1st, 2nd, 3rd, and ≥4th) showing median, quartiles, and full range of data. CSD-associated hypo- and hyperoxic ptiO2 response phases (areas of descINThypo or ascINThyper, see Fig 4B) are shown. With ascending order of CSDs within the clusters (D) areas of the initial hypoxic phase increased significantly in a stepwise fashion within clusters (n = 5, p = 0.011, Friedman test). (E) Areas of the secondary hyperoxic phase showed no significant alterations (n = 5, not significant); however, CSDs ≥4th in a cluster suggested a trend to higher areas. aU = arbitrary units.

References

    1. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007;3:256–263.
    1. Macdonald RL, Kassell F, Mayer S, et al. Clazosentan to overcome neurological Ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1) Stroke. 2008;39:3015–3021.
    1. Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus. 2006;21:E1.
    1. Dreier JP, Woitzik J, Fabricius M, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain. 2006;129:3224–3237.
    1. Leão AA. Spreading depression of activity in cerebral cortex. J Neurophysiol. 1944;7:41.
    1. Somjen GG. Aristides Leão's discovery of cortical spreading depression. J Neurophysiol. 2005;94:2–4.
    1. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81:1065–1096.
    1. Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Brain Res Rev. 2001;38:33–60.
    1. Fabricius M, Fuhr S, Bhatia R, et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain. 2006;129:778–790.
    1. Dohmen C, Sakowitz OW, Fabricius M, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63:720–728.
    1. Strong AJ, Hartings JA, Dreier JP. Cortical spreading depression: an adverse but treatable factor in intensive care? Curr Opin Crit Care. 2007;13:126–133.
    1. Nedergaard M, Hansen AJ. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res. 1988;449:395–398.
    1. Hossmann KA. Periinfarct depolarizations. Cerebrovasc Brain Metab Rev. 1996;8:195–208.
    1. Mies G, Iijima T, Hossmann KA. Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat. Neuroreport. 1993;4:709–711.
    1. Dreier JP, Major S, Manning A, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. 2009;132(pt 7):1866–1881.
    1. Dreier JP, Koerner K, Ebert N, et al. Nitric oxide scavenging by haemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab. 1998;18:978–990.
    1. Sonn J, Mayevsky A. Effects brain oxygenation on metabolic, hemodynamic, ionic and electrical response to cortical spreading depression in the rat. Brain Res. 2000;882:212–216.
    1. Shin HK, Dunn AK, Jones PB, et al. Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab. 2006;26:1018–1030.
    1. Strong AJ, Anderson PJ, Watts HR, et al. Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain. 2007;130:995–1008.
    1. Sukhotinsky I, Dilekoz E, Moskowitz MA, Ayata C. Hypoxia and hypotension transform the blood flow response to cortical spreading depression from hyperemia into hypoperfusion in the rat. J Cereb Blood Flow Metab. 2008;28:1369–1376.
    1. Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology. 1983;33:424–436.
    1. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
    1. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573–585.
    1. Nortje J, Gupta AK. The role of tissue oxygen monitoring in patients with acute brain injury. Br J Anaesth. 2006;97:95–106.
    1. Dohmen C, Bosche B, Graf R, et al. Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction. Stroke. 2007;(38):56–61.
    1. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, et al. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci. 2007;28:252–256.
    1. Uhl E, Lehmberg J, Steiger HJ, Messmer K. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery. 2003;52:1307–1317.
    1. Bevan JA, Bevan RD, Walters CL, Wellman T. Functional changes in human pial arteries (300 to 900 μm ID) within 48 hours of aneurysmal subarachnoid hemorrhage. Stroke. 1998;29:2575–2579.
    1. Sakowitz OW, Unterberg AW. Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Curr Opin Crit Care. 2006;2:103–111.
    1. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26:1341–1353.
    1. Back T, Kohno K, Hossmann KA. Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab. 1994;14:12–19.
    1. Dreier JP, Tille K, Dirnagl U. Partial antagonistic effect of adenosine on inverse coupling between spreading neuronal activation and cerebral blood flow in rats. Neurocrit Care. 2004;1:85–94.
    1. Jaeger M, Soehle M, Schuhmann MU, et al. Correlation of continuously monitored regional cerebral blood flow and brain tissue oxygen. Acta Neurochir (Wien) 2005;147:51–56.
    1. Vespa PM. Brain tissue oxygen monitoring: a measure of supply and demand. Crit Care Med. 2006;34:1850–1852.
    1. Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg. 2000;93:658–666.
    1. Kozniewska E, Michalik R, Rafalowska J, et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol. 2006;57:45–60.
    1. Obrenovitch TP, Urenjak J, Wang M. Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab. 2002;22:680–688.
    1. Dreier JP, Sakowitz OW, Harder A, et al. Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Ann Neurol. 2002;52:825–829.
    1. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004;113:1447–1455.
    1. Hashemi P, Bhatia R, Nakamura H, et al. Persisting depletion of brain glucose following cortical spreading depression, despite apparent hyperaemia: evidence for a risk of an adverse effect of Leao's spreading depression. J Cereb Blood Flow Metab. 2009;29:166–175.
    1. Takano T, Tian GF, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007;10:754–762.
    1. Feuerstein D, Manning A, et al. Local dynamic metabolic response to spontaneous spreading depolarisations in the penumbra of the acutely injured human brain. J Cereb Blood Flow Metab. 2009;29:S57. (Abstract 650)

Source: PubMed

3
Tilaa